Hager Bioscience, LLC

HAGER BIOSCIENCES, LLC is a preclinical-stage drug discovery company with innovative medicinal chemistry capabilities. Its mission to provide highly sought-after therapeutic leads for unmet medical needs. Hager’s discovery fragment pharmacophore platform, FragPhore®, provides a competitive advantage for efficient and rapid medicinal chemistry optimization of a drug candidate. The platform also improves pharmaceutical properties and provides modular fragments for intellectual property enhancement.